Schizophrenia Treatment:
Schizophrenia treatment information. Symptoms of schizophrenia and signs. Find latest research and information on schizophrenia and treatment.
-
Jan 7th, 2008
A medication that works well for one person with schizophrenia often doesn't work well for another. Genetic variations are thought to play a key role in this difference in response.
-
Dec 22nd, 2007
Forms of a gene known to increase risk for schizophrenia may create an imbalance in brain pathways for dopamine.
-
Dec 19th, 2007
Asenapine, a fast-dissolving, sublingual tablet being developed for treatment of schizophrenia, was more effective than placebo and well tolerated in treating patients with acute schizophrenia.
-
Dec 13th, 2007
INVEGA (paliperidone) Extended-Release Tablets showed favorable long-term safety and tolerability in schizophrenia treatment.
-
Dec 8th, 2007
Findings provide clues for why people with schizophrenia have lower rates of cancer.
-
Oct 29th, 2007
Schizophrenia may occur, in part, because of a problem in an intermittent on/off switch for a gene involved in making a key chemical messenger in the brain.
-
Oct 20th, 2007
Schizophrenia may occur, in part, because of a problem in an intermittent on/off switch for a gene involved in making a key chemical messenger in the brain
-
Oct 15th, 2007
Acutely ill, hospitalized patients with schizophrenia showed significant improvement in symptoms after taking INVEGA Extended-Release Tablets as compared to SEROQUEL and placebo.
-
Oct 10th, 2007
People with schizophrenia are falling further behind others when it comes to longevity.
-
Sep 11th, 2007
TorreyPines Therapeutics completed its third Phase I clinical trial for NGX267, in clinical development for the treatment of cognitive impairment associated with schizophrenia (CIAS).
